Levetiracetam is used for: Partial seizures.
Recorded in the NepalDoc medicine catalog for Levetiracetam.
Levetiracetam tablets USP are indicated for the treatment of partial-onset seizures in patients 1 month of age and older Levetiracetam tablets USP are indicated for adjunctive therapy for treatment of: Partial onset seizures in patients one month of age and older with epilepsy Myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy Primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy 1.1 Partial Onset Seizures Levetiracetam tablets USP are indicated for treatment of partial-onset seizures in patients 1 month of age and older.
From the U.S. FDA-approved label for Levetiracetam. Full label: DailyMed.
Levetiracetam tablets USP are indicated for the treatment of partial-onset seizures in patients 1 month of age and older Levetiracetam tablets USP are indicated for adjunctive therapy for treatment of: Partial onset seizures in patients one month of age and older with epilepsy Myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy Primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy 1.1 Partial Onset Seizures Levetiracetam tablets USP are indicated for treatment of partial-onset seizures in patients 1 month of age and older.
From the U.S. FDA-approved label for Levetiracetam. Full label: DailyMed.
Use the oral solution for pediatric patients with body weight ≤ 20 kg.
Directions from the U.S. FDA-approved label for Levetiracetam — your doctor or pharmacist may advise differently.
Known hypersensitivity to levetiracetam; angioedema and anaphylaxis have occurred Levetiracetam is contraindicated in patients with a hypersensitivity to levetiracetam. Reactions have included anaphylaxis and angioedema.
Excerpt from the U.S. FDA-approved label for Levetiracetam. Talk to a pharmacist or doctor before use.
Behavioral abnormalities including psychotic symptoms, suicidal ideation, irritability, and aggressive behavior have been observed; monitor patients for psychiatric signs and symptoms Suicidal Behavior and Ideation: Monitor patients for new or worsening depression, suicidal thoughts/behavior, and/or unusual changes in mood or behavior Monitor for somnolence and fatigue and advise patients not to drive or operate machinery until they have gained sufficient experience on levetiracetam Serious Dermatological Reactions: Discontinue levetiracetam at the first sign of rash unless clearly not drug related Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity: Discontinue if no alternative etiology Coordination Difficulties: Monitor for ataxia, abnormal gait, and incoordination.
Warnings and precautions excerpt from the U.S. FDA-approved label for Levetiracetam — not a complete list. Talk to a pharmacist or doctor before use.
Most common adverse reactions (incidence ≥5% more than placebo) include: Adult patients: somnolence, asthenia, infection and dizziness Pediatric patients: fatigue, aggression, nasal congestion, decreased appetite, and irritability To report SUSPECTED ADVERSE REACTIONS, contact Lupin Pharmaceutical Inc. at 1-800-399-2561 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Excerpt from the U.S. FDA-approved label for Levetiracetam — not a complete list. Talk to a pharmacist or doctor about side effects.
35 brands · 10 makers in the NepalDoc catalog — see the full Levetiracetam guide →
What is Levera 1?
Levera 1gm Tablet is a Levetiracetam medicine made by Intas Pharmaceuticals Ltd. It comes as 1gm Tablet.
What is Levera 1 used for?
Levetiracetam is used for Partial seizures.
What is the generic name of Levera 1?
The generic name of Levera 1 is Levetiracetam.
Which brands of Levetiracetam are available in Nepal?
35 brands of Levetiracetam are listed in the NepalDoc catalog, from 10 makers — including L Cetam 250mg Tablet, L Cetam 500mg Tablet, L-CETAM-750MG XR Tablet, Levacetam 500mg Tablet, Levera 500mg Injection, Levera 1000mg Tablet.
What are the side effects of Levetiracetam?
Most common adverse reactions (incidence ≥5% more than placebo) include: Adult patients: somnolence, asthenia, infection and dizziness Pediatric patients: fatigue, aggression, nasal congestion, decreased appetite, and irritability To report SUSPECTED ADVERSE REACTIONS, contact Lupin Pharmaceutical Inc.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
